Long-term benefits of airway clearance in bronchiectasis: a randomised placebo-controlled trial (vol 51, 1701926, 2018)

Munoz Gerard; de Gracia Javier; Buxo Maria; Alvarez Antonio; Vendrell Montserrat

首页> 外文期刊>The European respiratory journal : >Long-term benefits of airway clearance in bronchiectasis: a randomised placebo-controlled trial (vol 51, 1701926, 2018)

【24h】

Long-term benefits of airway clearance in bronchiectasis: a randomised placebo-controlled trial (vol 51, 1701926, 2018)

机译：支气管扩张的气道清关的长期效益：随机安慰剂对照试验（第51卷，1701926,2018）

获取原文

获取原文并翻译 | 示例

获取外文期刊封面目录资料

开具论文收录证明 >>

文献代查 >>

文献数据库（团队版） >>

页面导航

著录项
引文网络
相似文献
相关主题

著录项

来源
《The European respiratory journal :》 |2018年第4期|共1页
作者
Munoz Gerard; de Gracia Javier; Buxo Maria; Alvarez Antonio; Vendrell Montserrat;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类呼吸系及胸部疾病;
关键词

相似文献

外文文献
中文文献

1. Long-term benefits of airway clearance in bronchiectasis: a randomised placebo-controlled trial (vol 51, 1701926, 2018) [J] . Munoz Gerard, de Gracia Javier, Buxo Maria, The European respiratory journal : . 2018,第4期

机译：支气管扩张的气道清关的长期效益：随机安慰剂对照试验（第51卷，1701926,2018）
2. A 2 × 2 factorial, randomised, open-label trial to determine the clinical and cost-effectiveness of hypertonic saline (HTS 6%) and carbocisteine for airway clearance versus usual care over 52?weeks in adults with bronchiectasis: a protocol for the CLEAR clinical trial [J] . Judy Martina Bradley, Rohan Anand, Brenda O’Neill, Trials . 2019,第1期

机译：一个2×2因子，随机的开放标签试验，确定高渗盐水（HTS 6％）和携带型气道清关的临床和成本效果，而且通常护理超过52岁？有支气管扩张的成年人：清晰的议定书临床试验
3. Short-term effects of three slow expiratory airway clearance techniques in patients with bronchiectasis: a randomised crossover trial [J] . Herrero-Cortina B., Vilaro J., Marti D., Physiotherapy . 2016,第4期

机译：三种慢速呼气气道清除技术对支气管扩张患者的短期影响：一项随机交叉试验
4. Simulation used in conjunction with randomised control trials to evaluate the costs and benefits of a new drug [C] . Davies, R., Roderick, . 1998

机译：模拟与随机对照试验一起用于评估新药的成本和收益
5. A 2 × 2 factorial randomised open-label trial to determine the clinical and cost-effectiveness of hypertonic saline (HTS 6) and carbocisteine for airway clearance versus usual care over 52 weeks in adults with bronchiectasis: a protocol for the CLEAR clinical trial [O] . Judy Martina Bradley, Rohan Anand, Brenda O’Neill, 2019

机译：一项2×2析因随机开放标签的试验用于确定高渗盐水（6％的HTS）和卡波西汀用于气道通畅相对于常规治疗超过52周的成年人支气管扩张的临床和成本效益：CLEAR临床方案试用
6. “Long-term benefits of airway clearance in bronchiectasis: a randomised placebo-controlled trial.” Gerard Muñoz, Javier de Gracia, Maria Buxó, Antonio Alvarez and Montserrat Vendrell. Eur Respir J 2018; 51: 1701926. [O] . 2018

机译：“支气管扩张的气道清关的长期好处：随机安慰剂对照试验。” GerardMuñoz，javier de Gracia，MariaBuxó，Antonio Alvarez和Montserrat Vendrell。 EUR RESPIR J 2018; 51：1701926。

Long-term benefits of airway clearance in bronchiectasis: a randomised placebo-controlled trial (vol 51, 1701926, 2018)

著录项

引文网络

相似文献

相关主题

期刊订阅